Sovereign Immunity Protocols

The Enterprise's sovereign immunity derives from its Charter and the bilateral and multilateral treaty instruments to which it is party. These instruments establish the legal foundation for immunity from civil jurisdiction, execution, and prejudgment attachment, consistent with customary international law and the principles of sovereign equality.

Sovereign immunity applies to the Enterprise's core institutional activities, including treaty performance, capital allocation, diplomatic engagement, and constitutional governance. Commercial activities undertaken in the ordinary course of institutional operations may be subject to express waiver provisions as determined by the Board of Governors.

Questions of jurisdictional competence are determined by reference to the Charter, applicable treaties, and the principles of international law. The Enterprise maintains a policy of cooperating with host-state judicial authorities where consistent with its sovereign status, and disputes are resolved through the mechanisms prescribed in the applicable treaty instruments.